Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome

Journal of Addiction Medicine

Volumn 6, Issue 2, 2012, Pages 124-130

  Meyer, Marjorie ^a   Benvenuto, Anna ^a   Howard, Diantha ^b   Johnston, Anne ^c   Plante, Dawn ^a   Metayer, Jerilyn ^a   Mandell, Todd ^d  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b Department of Biostatisitcs ^*  (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d Drug Treatment Programs   (United States)

Author keywords

Opioid dependence; Pregnancy outcome; Treatment access

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; HEALTH CARE ACCESS; HUMAN; MATERNAL CARE; MONOTHERAPY; NEWBORN; NEWBORN ASSESSMENT; NEWBORN CARE; NEWBORN DEATH; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PERINATAL DRUG EXPOSURE; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

BUPRENORPHINE; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT, NEWBORN; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RURAL HEALTH SERVICES; RURAL POPULATION; TREATMENT OUTCOME; VERMONT;

EID: 84863638770     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3182541933     Document Type: Article

References (23)

1. Berkman ND, Wechsberg WM. Access to treatment-related and support services in methadone treatment programs. J Subst Abuse Treat 2007;32(1):97-104.
2. Borders TF, Booth BM. Research on rural residence and access to drug abuse services: where are we and where do we go? J Rural Health 2007;23(suppl):79-83.
3. Burns L, Mattick RP, Lim K, Wallace C. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2007;102(2):264-270.
4. Crabtree BF, Nutting PA, Miller WL, Stange KC, Stewart EE, Jaen CR. Summary of the National Demonstration Project and recommendations for the patient-centered medical home. Ann Fam Med 2010;8(suppl 1):S80-S90.
5. Fajemirokun-Odudeyi O, Sinha C, Tutty S, et al. Pregnancy outcome inwomen who use opiates. Eur J Obstet Gynecol Reprod Biol 2006;126(2):170-175.
6. Finnegan L. Neonatal Abstinence. Current Therapy in Neonatal-Perinatal Medicine. I. Toronto, Ontario, Canada: BC Decker; 1985:262-270.
7. Grella CE, Stein JA. Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders. Psychiatr Serv 2006;57(7):1007-1015.
8. Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag 2009;5(1):47-55.
9. Jones HE, Martin PR, Heil SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 2008;35(3):245-259.
10. Kahila H, Saisto T, Kivitie-Kallio S, Haukkamaa M, Halmesmaki E. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome. Acta Obstet Gynecol Scand 2007;86(2):185-190.
11. Kakko J, Heilig M, Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008;96(1/2):69-78.
12. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 1998;25(1):139-151.
13. Kandall SR, Gaines J, Habel L, Davidson G, Jessop D. Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr 1993;123(1):120-126.
14. Kashiwagi M, Arlettaz R, Lauper U, Zimmermann R, Hebisch G. Methadone maintenance program in a Swiss perinatal center: (I): management and outcome of 89 pregnancies. Acta Obstet Gynecol Scand 2005;84(2):140-144.
15. Kendall M. A new measure of rank correlation. Biometrika 1938; (30): 81-93.
16. Kinsman D. Joint Principles of a Patient-Centered Medical Home Released by Organizations Representing More Than 300, 000 Physicians. Available at: http://www.acponline.org/pressroom/pcmh.htm. Accessed July 30, 2010.
17. Koren G, Boucher N. Adverse effects in neonates exposed to SSRIs and SNRI in late gestation-Motherisk Update 2008. Can J Clin Pharmacol 2009;16(1):e66-e67.
18. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA 1993;269(15):1953-1959.
19. Passey M, Sheldrake M, Leitch K, Gilmore V. Impact of case management on rural women's quality of life and substance use. Rural Remote Health 2007;7(3):710.
20. Substance Abuse and Mental Health Services Administration. Available at: http://www.oas.samhsa.gov/substate2k6/ageDrugGap. htm. Accessed November 5, 2009.
21. US Census Bureau. Available at: http://www.census.gov/geo/www/ua/ urbanruralclass.html. Accessed November 5, 2009.
22. Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction 2008;103(9):1429-1440.
23. Yancovitz SR, Des Jarlais DC, Peyser NP, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991;81(9):1185-1191.